Distribution and marketing of drugs in Poland: overview

Publication | 01.11.2016

Overview of distribution and marketing of drugs law (pre-conditions for distribution, licensing, wholesale distribution, marketing to consumers and professionals and engagement with patient organisations).

Commercialisation of healthcare in Poland: overview

Publication | 01.11.2016

Overview of the regulatory framework for the commercialisation of medical products in Poland (requirements for drugs, medical devices, biological products and natural health products).

USP Zdrowie buys Polish-Swedish Naturell Group

Deals corner | 18.07.2016

USP Zdrowie Group acquired 100% of shares in the Polish-Swedish Naturell Group. We were the main adviser and co-ordinated the Polish-Swedish team of lawyers and tax and financial advisers.

DZP distinguished in Ist Ranking of Regulatory Law Firms 2016

News | 29.01.2016

28 January 2016 Polityka Insight announced the results of its first Ranking of Regulatory Law Firms 2016. Our law firm has been distinguished in three out of five categories: Pharmaceutical, Banking, Energy.

Pharmaceutical company owners merged with FMCG market leader

Deals corner | 23.10.2015

Maspex Wadowice Group purchased shares in Sequoia sp. z o.o. from a minority shareholder, Sorabot investment fund. Our Law Firm acted for the Sequoia majority shareholders.

DZP coordinates three-part transaction with GSK and Novartis

Deals corner | 26.05.2015

DZP advised GlaxoSmithKline in a three-part conditional transaction with Novartis AG in the following areas: health care means (Consumer Healthcare), vaccinations and cancer medicines.